Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
14 Cards in this Set
- Front
- Back
Factors contributing to prematurity
|
Medical and pregnancy history factors.
Current pregnancy problems. Socioeconomic factors. Daily habits or lifestyle factors. |
|
Infants at INCREASED risk for cold stress
|
SGA infants
Preterm infants Infants who suddenly become ill Any infant d/t large skin surface area/body weight If prolonged resuscitation is required |
|
Neutal thermal environment
|
An environment that allows the infant to expend the LEAST amount of energy in order to maintain a normal body temp.
(Minimal energy expenditure = lowest O2 consumption) |
|
Infant response to cold stress
|
Pulmonary vasoconstriction = incr. R to L Shunting = hypoxemia
Brown fat metab. = incr. O2 consumption Incr. movement & flexion = incr. O2 consumption Incr. metabolic rate = incr. O2 consumption Peripheral vasoconstriction = decr. O2 to tissues = hypoxia! |
|
Interventions to reduce heat loss
|
Preheat warmer, warm blankets, dry infant thoroughly, servo-control radiant warmer, cover the head, polyurethane bags for VLBW infants.
Servo-control radiant warmer, monitor temp., avoid drafts, delay the bath, pre-warm equipment, be alert to other sources of heat loss |
|
Respiratory distress syndrome
|
The major pulmonary problem occurring in the neonate.
The principle factor in the development of RDS is surfactant deficiency. Leads to atelectasis and loss of FRC |
|
Surfactant
|
Mixture of phospholipids & proteins found in mature alveoli. Reduces the surface tension within the alveoli
|
|
Signs of respiratory distress
|
Grunting, flaring, retractions
Rediographic Findings: fine reticulogranular pattern, air bronchograms |
|
Treatment of respiratory distress syndrome
|
Careful administration of oxygen
Monitoring of blood gases Ventilator therapy Use of CPAP Thermoregulation, treatment of hypoglycemia Surfactant replacement |
|
Antenatal steroids
|
Have been shown to increase lung maturation. Given to mothers when preterm delivery is anticipated (2 doses Q12-24 hours apart)
|
|
Bronchopulmonary Dysplasia
|
Chronic lung disease caused by oxygen toxicity and barotrauma/volutrauma resulting from pressure ventilation
Findings: Tachypnea, oxygen dependence, crackles, retractions; continue to require O2, CPAP. Most often in infants weighing <1500g @ birth |
|
Patent Ductus Arteriosus
|
More likely to develop BPD.
PDA symptoms: Murmer, active precordium, bounding peripheral pulses, tachypnea, widened pulse pressures, incr. respiratory support, pulmonary edema |
|
Benefits of mother's milk
|
resistance to infectious disease
enhanced immune system nutritional and growth benefitsreduced risk for chronic diseases developmental benefits improved maternal health socioeconomic benefits |
|
Mother's milk as a "medicine" for VLBW
|
Protects from handicapping and conditions specific to premature infants (infection, necrotizing enterocolitis)
Provides fatty acids to support brain and eye tissue development |